ISSN 2398-2942      

Mast cell tumor: chemotherapy protocols

icanis

Introduction

  • The following chemotherapy protocols for mast cell tumors will be covered:
    • Protocol 1: Vinblastine/prednisolone protocol.
    • Protocol 2: Alternating vinblastine/cyclophosphamide + prednisolone protocol.
    • Protocol 3: Alternating vinblastine/lomustine + prednisolone protocol.
    • Protocol 4: CCNU + prednisolone.
    • Protocol 5: Tyrosine kinase inhibitors (TKI). 
    • Protocol 6: Chlorambucil + prednisolone. 

Protocols are not listed in order of preference or efficacy.Do not use without consulting specialist oncologist.Refer to chemotherapy safety administration Chemotherapy: safe handling.

Protocol 1

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 2

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 3

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 4

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 5

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Protocol 6

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Legal and safety precautions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Olsen J A, Thomson M, O'Connell K, Wyatt K (2018) Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs. J Vet Med Sci 4 (3), 237-251 PubMed.
  • Tjostheim S S, Stepien R L, Markovic L E, Stein T J (2016) Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs. J Vet Intern Med 30(4), 951-957 PubMed
  • Grant J, North S, Lanore D (2016) Clinical response of masitinib mesylate in the treatment of canine macroscopic mast cell tumours. JSAP 57(6), 283-290 PubMed.
  • Smrkovski O A, Essick L, Rohrbach B W, Legendre A M (2015) Masitinib mesylate for metastatic and non‐resectable canine cutaneous mast cell tumours. Vet Comp Oncol 13(3), 314-321 PubMed.
  • Carlsten K S, London C A, Haney S, Burnett R,  Avery A C, Thamm D H (2012) Multicenter Prospective Trial of Hypofractionated Radiation Treatment, Toceranib, and Prednisone for Measurable Canine Mast Cell Tumors. J Vet Intern Med 26(1), 135-141 PubMed.
  • Hahn K A, Legendre A M, Shaw N G, Phillips B, Ogilvie G K et al (2010) Evaluation of 12- and 24-month survival rates after treatment withmasitinib in dogs with nonresectable mast cell tumors. Am J Vet Res 71 (11), 1354-1361 PubMed.
  • London C A, Malpas P B, Wood-Follis S L, Boucher J F, Rusk A W et al (2009) Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision. Clin Cancer Res 15 (11), 3856-3865 PubMed.
  • Taylor F, Gear R, Hoather T et al (2009) Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumors: 21 cases. JSAP 50 (6), 284-289 PubMed.
  • Hahn K A, Oglivie G, Rusk T et al (2008) Masitinib Is Safe and Effective for the Treatment of Canine Mast Cell Tumors. JVIM 22(6), 1301-1309 PubMed.
  • Camps-Palau M A, Leibman N F, Elmslie R et al (2007) Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997-2004). Vet Comp Oncol (3), 156-167 PubMed.
  • Thamm D H, Turek M M, Vail D M (2006) Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases. J Vet Med Sci 68 (6), 581-587 PubMed.
  • Kristal O, Rassnick K M, Gliatto J M et al (2004) Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. J Vet Intern Med 18 (1), 75-80 PubMed.
  • Charney S C, Bergman P J, Hohenhaus A E et al (2003) Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996). J Am Vet Med Assoc 222 (10), 1388-1393 PubMed.
  • Rassnick K M, Moore A S, Williams L E et al (1999) Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13 (6), 601-605 PubMed.
  • Thamm D H, Mauldin E A, Vail D M (1999) Prednisone and vinblastine chemotherapy for canine mast cell tumor - 41 cases (1992-1997). J Vet Intern Med 13 (5), 491-497 PubMed.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!

 
 
 
 

To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code